Labador, Marilyn A.
HRN: 26-79-22 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/12/2025
CEFTRIAXONE 1G (VIAL)
03/12/2025
03/19/2025
IV
2gms
Od
Typhoid Fever
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes